key: cord-0817063-upvr1jw6
authors: Choron, Rachel L.; Butts, Christopher A.; Bargoud, Christopher; Krumrei, Nicole J.; Teichman, Amanda L.; Schroeder, Mary E.; Bover Manderski, Michelle T.; Cai, Jenny; Song, Cherry; Rodricks, Michael B.; Lissauer, Matthew; Gupta, Rajan
title: Fever in the ICU: A Predictor of Mortality in Mechanically Ventilated COVID-19 Patients
date: 2020-12-15
journal: J Intensive Care Med
DOI: 10.1177/0885066620979622
sha: 3b1fcf6aaf7907c468ed946681dae7f91ce4d0b8
doc_id: 817063
cord_uid: upvr1jw6

PURPOSE: While fever may be a presenting symptom of COVID-19, fever at hospital admission has not been identified as a predictor of mortality. However, hyperthermia during critical illness among ventilated COVID-19 patients in the ICU has not yet been studied. We sought to determine mortality predictors among ventilated COVID-19 ICU patients and we hypothesized that fever in the ICU is predictive of mortality. MATERIALS AND METHODS: We conducted a retrospective cohort study of 103 ventilated COVID-19 patients admitted to the ICU between March 14 and May 27, 2020. Final follow-up was June 5, 2020. Patients discharged from the ICU or who died were included. Patients still admitted to the ICU at final follow-up were excluded. RESULTS: 103 patients were included, 40 survived and 63(61.1%) died. Deceased patients were older {66 years[IQR18] vs 62.5[IQR10], (p = 0.0237)}, more often male {48(68%) vs 22(55%), (p = 0.0247)}, had lower initial oxygen saturation {86.0%[IQR18] vs 91.5%[IQR11.5], (p = 0.0060)}, and had lower pH nadir than survivors {7.10[IQR0.2] vs 7.30[IQR0.2] (p < 0.0001)}. Patients had higher peak temperatures during ICU stay as compared to hospital presentation {103.3°F[IQR1.7] vs 100.0°F[IQR3.5], (p < 0.0001)}. Deceased patients had higher peak ICU temperatures than survivors {103.6°F[IQR2.0] vs 102.9°F[IQR1.4], (p = 0.0008)}. Increasing peak temperatures were linearly associated with mortality. Febrile patients who underwent targeted temperature management to achieve normothermia did not have different outcomes than those not actively cooled. Multivariable analysis revealed 60% and 75% higher risk of mortality with peak temperature greater than 103°F and 104°F respectively; it also confirmed hyperthermia, age, male sex, and acidosis to be predictors of mortality. CONCLUSIONS: This is one of the first studies to identify ICU hyperthermia as predictive of mortality in ventilated COVID-19 patients. Additional predictors included male sex, age, and acidosis. With COVID-19 cases increasing, identification of ICU mortality predictors is crucial to improve risk stratification, resource management, and patient outcomes.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, Hubei Province, China in December 2019. Coronavirus disease has resulted in a global pandemic subsequently spreading to 188 countries and territories. Over 18.1 million people have been infected, resulting in more than 690,000 deaths world-wide, 1 and over 4.6 million people in the United States have been infected, 154,471 of whom have died as of the manuscript submission date August 3, 2020. 2 While overall mortality for all people infected with COVID-19 is about 0.5%, 1 reported mortality for patients presenting to a hospital ranges widely among geographic regions, 3.4-24.3%. [3] [4] [5] Mortality among COVID-19 patients admitted to the ICU has been variably reported from 17-88%. [5] [6] [7] [8] [9] [10] Varying ICU admission criteria, geographic locations, resource availability, and admission volume rates may contribute to disparate mortality rates across institutions and countries during the pandemic.

COVID-19 is being researched broadly and several studies have reported characteristics and outcomes of hospitalized COVID-19 patients with the intent to identify predictors and risk factors for the development of severe disease, need for ICU admission, and mortality. 3, [11] [12] [13] [14] [15] Described predictors for developing severe COVID-19 disease include older age, pre-existing comorbidities, obesity, hypoxia on admission, and variable biomarker abnormalities. 3, [11] [12] [13] [14] [15] One relevant online prediction model, the ISARIC WHO Clinical Characterisation Protocol, used a derivation dataset based on 35,463 patients from 260 hospital across England, Scotland and Wales to create the 4C Mortality Score based on 8 variables from initial hospital assessment. 16 While this performed strongly against other prediction models, models vary in setting, predicted outcome measure, and included clinical parameters, which result in application challenges, especially when applied to small cohorts as the authors note. 16 Less data exist regarding risk factors and predictors for mortality once a patient is already critically ill. For intensivists taking care of critically ill COVID-19 patients requiring invasive mechanical ventilation (IMV), it is crucial to identify factors which prognosticate mortality.

As our hospital surged with critically ill COVID-19 patients, we started recognizing clinical patterns of disease. One notable recurrent finding was persistent high-grade fevers in the ICU. While many studies have described fever as a presenting symptom of COVID-19 patients, 15 few studies have identified fever as predictive of mortality. 11 While most literature has described initial temperature upon hospital presentation to evaluate for mortality, as opposed to peak temperature during ICU admission, a recent study from affiliated hospitals in the New York area revealed body temperature on presentation 36 C was associated with the highest mortality and maximum temperature during hospital course correlated with mortality rate as well; they found a 42% mortality rate for body temperature >40 C. 17 Conversely Zheng et al. suggested that fever was associated with the progression of severe COVID-19 disease 18 and a meta-analysis of 15 articles including 2,851 COVID-19 patients found fever was not significantly associated with mortality. 19 While conflicting research exists regarding the association of fevers with mortality in COVID-19, we anecdotally noted fevers on admission were not as high as fevers during critical illness. Additionally, patients with particularly high fevers seemed to have worse outcomes.

We therefore sought to determine predictors of mortality in critically ill COVID-19 ICU patients requiring IMV. We hypothesized that hyperthermia in the ICU is a predictor of mortality among critically ill COVID-19 patients.

This was a retrospective study of the first 108 consecutive COVID-19 positive patients admitted to the ICU requiring IMV. Patients included were admitted over a 10-week period from March 14, 2020 to May 27, 2020. The Institutional Review Board approved this study as minimal risk.

All patients requiring ICU admission and IMV, with confirmed COVID-19 by positive polymerase chain reaction (PCR) testing of nasopharyngeal sample for SARS-CoV-2, and were subsequently discharged from the ICU or who died were included. Patients who remained admitted to the ICU at the study endpoint were excluded.

Final follow-up date was June 5, 2020. At the study endpoint, 103 of 108 patients met inclusion criteria, 2 of whom remained hospitalized but were no longer in the ICU. The 5 excluded patients were still admitted to the ICU and therefore not included.

This study was performed at a 297-bed community hospital in Central New Jersey which is part of one of the largest healthcare systems in the state. Prior to the pandemic, the ICU capacity was 16 beds, with an average ICU census of 10, and a daily average IMV census of 3. During the study period at the height of the pandemic, the ICU capacity was increased to 35 beds with additional patients boarding in the emergency department. At the peak of the crisis, 38 patients required IMV simultaneously. Board certified surgical and anesthesia critical care intensivists provided care to all ICU patients 24 hours a day, 7 days a week. Workflow and structural changes were made to provide additional surgical intensivist surge coverage.

Data were abstracted from the electronic medical record (Allscripts-Sunrise Clinical Manager, Chicago, IL). A standardized data abstraction form was created and important variables were defined. Abstractors were trained on the utilization of the data abstraction form prior to data gathering. Patient assignment was not blinded to the abstractors and the abstractors' performance was monitored by the principal investigator. Interrater reliability and interrater agreement was not monitored. Data collected from the medical record included patient demographics, pre-existing comorbidities, vital signs, laboratory tests, imaging studies, complications, and outcomes including length of stay, ventilator days, and mortality. Temperatures were measured either by temperature sensing bladder, rectal, esophageal, or central venous probes.

High-grade fever was defined as temperature greater or equal to 103 degrees Fahrenheit ( F). Treatment using targeted temperature management systems was per the discretion of the attending intensivist and limited to availability. As previously reported, acute kidney injury (AKI) was based on the Kidney Disease: Improving Global Outcomes (KDIGO) definition as an increase in serum creatinine by 0.3 mg/dL within 48 hours or an increase of at least 1.5 times baseline within 7 days. 20 Acute hepatic injury was defined as aspartate aminotransferase or alanine transaminase 15 times the upper limit of normal. Acute respiratory distress syndrome (ARDS) was defined by the Berlin criteria. 21 Secondary infectious complications including pneumonia, bacteremia, and urinary tract infections were defined by positive culture data. Clostridium difficile infection was defined by positive stool PCR testing. Shock was defined by a vasopressor requirement to maintain a mean arterial pressure greater than 65 mmHg. New arrhythmias associated with hemodynamic instability, myocardial infarctions with increased biomarkers or new abnormalities on electrocardiography, and cardiomyopathy with newly depressed contractility on transthoracic echocardiography defined cardiac complications. Chest radiograph was used to define a new pneumothorax. Deep vein thrombosis on duplex ultrasonography or pulmonary embolism on computed tomography angiography defined venous thromboembolism. New ischemic lesions or intracranial hemorrhage on computed tomography or magnetic resonance imaging, or seizures identified by electroencephalogram defined neurologic complications.

Median and interquartile range (IQR) were reported for all continuous variables, since most were determined to be nonnormally distributed according to the Shapiro-Wilk statistic. 22 The significance of bivariate associations were tested using Pearson's Chi-Square test, except when small cell counts warranted use of Fisher's Exact test; continuous variables were compared using 2-sided Wilcoxon Rank-Sum test. For variables found to be significantly associated in bivariate analysis (p < 0.05), risk ratios (RR) were estimated using modified (i.e., robust variance estimator) Poisson regression. 23 For ease of interpretation, continuous predictors were modeled as binary based on clinical cut points (88% oxygen saturation, creatinine >1.2 mg/dL, lactate >2 mmol/L, ferritin >335 ng/mL, pH nadir < 7.2, peak temperature 104 F). Multivariable regression analyses subsequently estimated the risk of mortality for patients with peak temperature of at least 104.0 F (vs. lower) adjusted for age and sex (Model 1); age, sex, and pH nadir (Model 2); and age, sex, pH nadir, initial oxygen saturation, and lowest P/F ratio (Model 3). (Table 3) . Shock requiring vasopressors, acute kidney injury, and acute hepatic injury were significantly higher among deceased patients (all p < 0.05) ( Table 2 )}. High grade fevers greater than 103 F during critical illness in the ICU were significantly more common among the deceased patients. A direct relationship was identified between temperature and mortality: as peak temperature increased among COVID-19 IMV patients, mortality increased as well (Figure 1 ). While overall mortality was 61.1% for the studied population, mortality was lower (40%) among patients with peak temperature less than 102 F. Conversely, mortality was higher (70.6%) among patients with peak temperature greater than 104 F and there was 100% mortality among the 14 patients who had hyperthermia greater than 105 F. There was no difference in outcome among the 11 patients treated with a non-invasive targeted temperature management system (Arctic Sun TM Temperature Management System, Covington, GA). Conversely of the 18 patients treated with invasive temperature management systems (ZOLL, ZOLL Medical Corporation), 2 survived. Overall 26 (25.2%) COVID-19 ICU patients received targeted temperature management (3 patients received both non-invasive and invasive temperature management systems during their hospital course), among that population 21 (80.8%) died and 5 (19.2%) survived (p ¼ 0.018). 

In univariable analysis, risk of death increased by about 1% with each year of age (RR, 1.01; 95% confidence interval [CI], 1.00-1.03) and was 51% higher among males than females (RR 1.51; 95% CI, 1.01-2.26) (Table 4A) . Having an initial oxygen saturation less than 88% was associated with 59% (RR, 1.59; 95% CI, 1.14-2.21) increased risk of death, and patients with pH nadir less than 7.2 had more than 2.5 times (RR 2.58; 95% CI, 1.65-4.05) risk of death relative to those with higher pH. Mortality risk for those with peak temperature of at least 103 F was 41% higher (RR, 1.41; 95% CI, 0.99-2.01) than those with a lower peak temperature and 68% higher (RR, 1.68; 95% CI, 1.27-2.22) if peak temperature was greater than 104 F. The effect of peak temperature, as well as age, sex, and pH nadir, remained significant in multivariable analysis as predictors of mortality. Whereas, initial oxygen saturation and lowest P/F ratio were no longer significant predictors of mortality risk after adjusting for these factors (Table 4B) . Peak temperature remained a significant predictor of mortality after adjusting for initial oxygen saturation <88% and lowest P/F ratio. When adjusting for these risk factors, mortality was 2% higher with age and 48% higher for men. Peak temperature was found to have an even greater impact on mortality. Mortality was 60% higher among patients with peak temperatures of 104 F than those with lower temperatures when adjusting for age sex, pH nadir, initial O2 saturation <88%, and P/F ratio nadir; this risk was even higher when adjusting for only age and sex, resulting in 75% higher mortality (aRR 1.75; 95% CI, 1.31-2.32) (Table 4B) .

Univariate analysis was repeated among the 77 critically ill COVID-19 patients who did not receive targeted temperature 

This retrospective cohort study identified fever, male sex, increasing age, and acidosis as predictive of mortality in ventilated COVID-19 patients. Prediction models for developing severe COVID-19 infections requiring ICU admission are emerging within the academic literature 3, 15 ; however there are limited data regarding predictors of mortality among patients who already have severe disease. This work represents one of the first studies to identify hyperthermia in the ICU as a predictor of mortality in mechanically ventilated COVID-19 patients. As the COVID-19 pandemic spread, fever was identified as a common presenting symptom and predictor of the presence of COVID-19. 15 However, prior studies that sought to determine predictors of mortality in hospitalized COVID-19 patients did not identify fever as a risk factor. 3, [11] [12] [13] [14] [15] 19 These studies typically used temperature upon hospital presentation for the evaluation. In our cohort, median temperature upon hospital presentation was consistent with a low-grade fever (100.0 F [IQR 3.5]) and not significantly different among survivors compared to decedents; accordingly, temperature on admission was not predictive of mortality. Conversely, peak temperature during critical illness among ventilated COVID-19 patients in the ICU was significantly higher than admission temperature and consistent with high-grade fever (103.3 F [IQR 1.7] vs 100.0 F [IQR 3.5]) (p < 0.0001).

Moreover, high-grade fevers were found to be common among COVID-19 ICU patients, with 56.3% of patients experiencing peak temperatures of 103 F and 30.1% greater than 104 F. When evaluating peak temperature in the ICU, it was significantly higher among deceased COVID-19 patients as Figure 1 . A direct relationship between temperature and mortality: as peak temperature increased, mortality increased as well among COVID-19 mechanically ventilated patients. compared to survivors (p ¼ 0.0008). Furthermore, multivariate analysis confirmed hyperthermia in the ICU to be a significant predictor of mortality and resulted in a 75% greater risk of mortality (Table 4 ). This study went on to demonstrate a direct correlation between temperature and mortality: as peak temperature increased among COVID-19 IMV patients, mortality increased as well, with 100% mortality in the 14 patients with fevers greater than 105 F. The purpose in identifying predictors of mortality is not only to develop prognostic information but also to identify predictors that expedite intervention to improve outcomes. While predictors such as age and gender cannot be changed, hyperthermia can be treated and normothermia can be achieved; however, it is unclear whether targeted temperature management is beneficial or harmful in the setting of sepsis. The CASS study, a randomized controlled trial of 436 patients with severe sepsis or septic shock were randomized to routine thermal management or induced hypothermia (target temperature 32-34 C) for 24 hours followed by normothermia (36-38 C) for 48 hours; the trial was stopped for futility as 44.2% of patients in the hypothermia group died compared to 35.8% in the routine thermal management group (p ¼ 0.07). 24 A second randomized controlled trial in patients who presented to the emergency department with septic shock were treated with standard fever control vs intensive fever control maintaining normothermia below 37 C; this study was stopped secondary to a slow enrollment rate and the presence of adverse effects, namely shivering, in the therapeutic normothermia group. 25 While there has been some controversy as to whether normothermia should be pursued in febrile ICU patients as it could be harmful, evidence from Schortgen et al demonstrated fever control using external cooling devices in a randomized controlled trial reduced 14-day mortality in ICU patients with septic shock; however this study had limitations including lack of power to examine mortality, baseline differences among the 2 groups with the control group being more critically ill, and ultimately no difference in mortality at ICU or hospital discharge. 26 While, mortality benefits of fever control in septic shock include decreased oxygen consumption, hemodynamic stabilization, and decreased vasopressor requirements, meta-analyses of randomized controlled trials did not support that more active fever management increased survival compared to less active fever management in patients with limited physiological reserves. 27, 28 Retrospective and observational studies have even suggested benefit to elevated temperatures which in turn enhance the immune system and inhibit pathogen infectivity. [29] [30] [31] [32] [33] [34] [35] Our practice pattern was to utilize external or systemic temperature management devices to combat severe hyperthermia with the goal of inducing normothermia, not hypothermia. This practice pattern was left to the discretion of the attending intensivist as temperature management devices were limited and continually triaged among patients with the most severe hyperthermia. While it cannot be determined whether temperature management had a direct effect on outcomes as the devices were triaged to the most critically ill patients, the majority of patients who died {40 patients (63.5%)}, did not receive targeted temperature management but still experienced high grade fevers; this supports the findings in this study that high grade fevers were common and associated with increased mortality. Additionally, when repeating univariable and multivariable analyses of the 77 patients who did not receive targeted temperature management, the results were similar indicating mortality remained higher among patients with higher peak temperatures; this suggests while targeted temperature management could be a confounder in this study, when it was removed from analysis, peak hyperthermia remained significantly associated with mortality.

Our study has important limitations. This was a retrospective observational trial without intervention performed for analysis. While continuous predictors were modeled as binary based on clinical cut points for ease of interpretation in the multivariable analysis, this could potentially uncover nonlinear relationships or inflate the type I error rate. A confounder within this study is the non-uniform use of temperature management systems and the inability to determine the effect on outcomes. Future studies are therefore needed to determine whether targeted temperature management in COVID-19 ICU patients results in a mortality benefit. Currently a pilot randomized controlled trial (ClinicalTrials.gov Identifier: NCT02706275) is enrolling septic patients, including COVID-19 patients, comparing outcomes in patients externally warmed to 1.5 C greater than their baseline minimum temperature within the previous 24 hours to a control group that receives standard body temperature management. As this pandemic continues and ICU COVID-19 volumes continue to surge, it is important to be aware of the effect of hyperthermia on mortality and to determine the optimal temperature management strategy to improve patient outcomes.

In this retrospective study of critically ill mechanically ventilated COVID-19 patients admitted to a community hospital ICU, predictors of mortality were ICU hyperthermia, male sex, increasing age, and acidosis. Severe hyperthermia was common and increasing temperatures were independently associated with increasing mortality rates. The utilization of targeted temperature management did not have an effect on outcomes. As COVID-19 becomes even more prevalent, identification of predictors of mortality in ICU patients is critical.

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Coronavirus COVID-19 global cases

Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study

Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area

Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study

Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State

Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region

Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study

ICU and ventilator mortality among critically Ill adults with coronavirus disease 2019

Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pneumonia

Predictors for Severe COVID-19 Infection

Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States

Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis

Prediction models for diagnosis and prognosis of COVID-19 infection: systematic review and critical appraisal

Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C mortality score

Body temperature correlates with mortality in COVID-19 patients

Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis

Dyspnea rather than fever is a risk factor for predicting mortality in patients with COVID-19

Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group: KDIGO clinical practice guideline for acute kidney injury

The ARDS definition Task Force. Acute respiratory distress syndrome the berlin definition

An analysis of variance test for normality (complete samples)

A modified Poisson regression approach to prospective studies with binary data

Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trial

Intensive fever control using a therapeutic normothermia protocol in patients with febrile early septic shock: a randomized feasibility trial and exploration of the immunomodulatory effects

Fever control using external cooling in septic shock: a randomized controlled trial

Fever control in critically ill adults. An individual patient data meta-analysis of randomised controlled trials

Effect of active temperature management on mortality in intensive care unit patients

Fever: suppress or let it ride?

Early temperature and mortality in critically ill patients with acute neurological diseases: trauma and stroke differ from infection

Antipyretic therapy in critically Ill septic patients: a systematic review and meta-analysis

The association of fever and antipyretic medication with outcomes in mechanically ventilated patients: a cohort study

Fever and the thermal regulation of immunity: the immune system feels the heat

Elevation in body temperature to fever range enhances and prolongs subsequent responsiveness of macrophages to endotoxin challenge

Counterpoint: should antipyretic therapy be given routinely to febrile patients in septic shock?